Overexpression of DcR3 and its significance on tumor cell differentiation and proliferation in glioma

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Huang, Suning ^a,b   Chen, Gang ^b   Dang, Yiwu ^b   Chen, Long Hua ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DECOY RECEPTOR 3; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; CYCLINE; TNFRSF6B PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BRAIN TISSUE; CANCER CELL CULTURE; CANCER GRADING; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLOW UP; GANGRENE; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SUPERNATANT; TUMOR DIFFERENTIATION; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING; BRAIN TUMOR; CANCER STAGING; CASE CONTROL STUDY; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENETICS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; YOUNG ADULT;

ADULT; AGED; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GLIOMA; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; YOUNG ADULT;

EID: 84898901589     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/605236     Document Type: Article

References (19)

1. Morishige T., Yoshioka Y., Inakura H., Tanabe A., Yao X., Tsunoda S.-I., Tsutsumi Y., Mukai Y., Okada N., Nakagawa S., Creation of a lysine-deficient LIGHT mutant with the capacity for site-specific PEGylation and low affinity for a decoy receptor. Biochemical and Biophysical Research Communications 2010 393 4 888 893 2-s2.0-77949486399 10.1016/j.bbrc.2010.02.119
2. Connor J. P., Felder M., Kapur A., Onujiogu N., DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1. BMC Cancer 2012 12, article 176 10.1186/1471-2407-12-176
3. Wang W., Zhang M., Sun W., Yang S., Su Y., Zhang H., Liu C., Li X., Lin L., Kim S., Okunieff P., Zhang Z., Zhang L., Reduction of decoy receptor 3 enhances TRAIL-mediated apoptosis in pancreatic cancer. PloS ONE 2013 8 10 e74272 10.1371/journal.pone.0074272
4. Yang D., Fan X., Yin P., Wen Q., Yan F., Yuan S., Liu B., Zhuang G., Liu: Z., Significance of decoy receptor 3 (Dcr3) and external-signal regulated kinase 1/2 (Erk1/2) in gastric cancer. BMC Immunology 2012 13, article 28 10.1186/1471-2172-13-28
5. Chen G., Luo D., Expression of decoy receptor 3 in liver tissue microarrays. The National Medical Journal of India 2008 21 6 275 278 2-s2.0-65349154749
6. Chen G., Luo D., Over-expression of decoy receptor 3 in gastric precancerous lesions and carcinoma. Upsala Journal of Medical Sciences 2008 113 3 297 304 2-s2.0-56749136445
7. Chen G., Rong M., Luo D., TNFRSF6B neutralization antibody inhibits proliferation and induces apoptosis in hepatocellular carcinoma cell. Pathology 2010 206 9 631 641 2-s2.0-77956011978 10.1016/j.prp.2010.05.011
8. Yang M., Chen G., Dang Y., Luo D., Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients. Upsala Journal of Medical Sciences 2010 115 4 232 237 2-s2.0-77958530304 10.3109/03009734.2010.516410
9. Roth W., Isenmann S., Nakamura M., Platten M., Wick W., Kleihues P., Bähr M., Ohgaki H., Ashkenazi A., Weller M., Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Research 2001 61 6 2759 2765 2-s2.0-0035866822
10. Arakawa Y., Tachibana O., Hasegawa M., Miyamori T., Yamashita J., Hayashi Y., Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma. Acta Neuropathologica 2005 109 3 294 298 2-s2.0-23844543122 10.1007/s00401-004-0956-6
11. Hwang S.-L., Lin C.-L., Cheng C.-Y., Lin F. A., Lieu A.-S., Howng S.-L., Lee K.-S., Serum concentration of soluble decoy receptor 3 in glioma patients before and after surgery. The Kaohsiung Journal of Medical Sciences 2004 20 3 124 127 2-s2.0-1942470937
12. Chen G., Noor A., Kronenberger P., Teugels E., Umelo I. A., de Greve J., Synergistic effect of afatinib with su11274 in non-small cell lung cancer cells resistant to gefitinib or erlotinib. PloS ONE 2013 8 3 e59708 10.1371/journal.pone.0059708
13. Chen G., Umelo I. A., Lv S., Teugels E., Fostier K., Kronenberger P., Dewaele A., Sadones J., Geers C., de Grève J., miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PloS ONE 2013 8 3 e60317 10.1371/journal.pone.0060317
14. Dang Y., Luo D., Rong M., Chen G., Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET. PloS ONE 2013 8 4 e61054 10.1371/journal.pone.0061054
15. Rong M., Chen G., Dang Y., Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro. BMC Cancer 2013 13, article 21 10.1186/1471-2407-13-21
16. Ao R., Du Y.-Q., Wang Y., Chen Y.-S., Wang B.-Y., MMP-2 and DcR3 expression in esophageal cancer tissue and correlation with patient survival. International Journal of Clinical and Experimental Medicine 2013 6 8 700 705
17. Zhou J., Song S.-D., Li D.-C., Zhou J., Zhu D.-M., Zheng S.-Y., Clinical significance of expression and amplification of the DcR3 gene in pancreatic carcinomas. Asian Pacific Journal of Cancer Prevention 2012 13 2 719 724 10.7314/APJCP.2012.13.2.719
18. Xiong G., Guo H., Ge X., Xu X., Yang X., Yang K., Jiang Y., Bai Y., Decoy receptor 3 expression in esophageal squamous cell carcinoma: correlation with tumour invasion and metastasis. Biomarkers 2011 16 2 155 160 2-s2.0-79951941094 10.3109/1354750X.2010.536258
19. Ge Z., Sanders A. J., Ye L., Wang Y., Jiang W. G., Expression of death decoy receptor-3 (DcR3) in human breast cancer and its functional effects on breast cancer cells in vitro. Journal of Experimental Therapeutics & Oncology 2011 9 2 109 118 2-s2.0-79959247083